FY23 Corporate Strategy and Sustainability Journey

The Industry is facing a shift and we are investing to lead Our Approach: Anchored in our Purpose Fulfills an unmet need Meaningful opportunity End-to-End Right to Win disease thinking ooooo Scaling-up Immuno-oncology NCES CDMO www 00 Horizon 2 areas Nutraceuticals New spaces Differentiated Formulations Preventive & Primary Care Platform SVAAS Biologics and Cell & Gene therapy Disease management ... and more 22 copyright Dr. Reddy's Ltd.

View entire presentation